Container1 (Container1)
Dasatinib Tablet, Film Coated
Product Images NDC 43598-604
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dasatinib (NDC 43598-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dr.reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Container2 (Container2)
Container3 (Container3)
This is a medical label for NDC 43598-601-60 ib Tablets containing 70 mg. It provides instructions to swallow tablets whole and not to crush, cut, or chew them. This medication is available in a package containing 60 tablets and is for prescription use only.*
Container4 (Container4)
The text provided appears to be a description of a prescription medication in tablet form. The dosage is 80 mg, and the instructions state to swallow the tablets whole, without crushing, cutting, or chewing them. The name of the medication "Dasat" is mentioned, and it is indicated for prescribed use only with a pack containing 30 tablets.*
Container5 (Container5)
Container6 (Container6)
This is a product description for Dr. Reddy's Dasatini Tablets with 140 mg dosage. The tablets are intended to be swallowed whole and must not be crushed, cut, or chewed. The text also includes prescription information stating "Rx Only" and indicates that there are 30 tablets in the package.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
